Target intelligence / Profile preview

Chloride channel protein 4 (CLCN4)

Target
CLCN4
Molecular classification
Ion channel, Transporter
01

Overview

Chloride channel protein 4 (CLCN4) is a member of the CLC family of chloride channels and chloride/proton exchangers. It is primarily an electrogenic H(+)/Cl(-) exchanger that mediates the exchange of chloride ions for protons across intracellular membranes, especially in endosomal and organellar compartments. CLCN4 is highly expressed in the brain and is thought to play roles in ion homeostasis, endosomal pH regulation, and intracellular trafficking. Mutations in CLCN4 are associated with X-linked neurodevelopmental disorders including intellectual disability, early-onset epilepsy, behavioral and movement disorders, and microcephaly. The CLCN4 gene is located on the X chromosome at Xp22.3, and both loss- and gain-of-function mutations have been observed in patients, leading to complex clinical phenotypes. As of now, no drugs are approved that specifically modulate CLCN4, and it is considered an emerging target for rare genetic disorders rather than for common, druggable diseases.

Other names
H(+)/Cl(-) exchange transporter 4ClC-4CLC4ClC-4Achloride transporter ClC-4MRX15MRX49MRXSRCchloride channel 4voltage-sensitive chloride channel 4
02

Mechanism of action

Not applicable (no known drugs); theoretical mechanisms would involve modulation of chloride–proton antiport activity

03

Biological functions

Chloride–proton exchangeIon homeostasisEndosomal/organellar pH regulationIntracellular trafficking
04

Disease associations

Neurodevelopmental disorderIntellectual disabilityEpilepsyBehavioural disordersMovement disordersMicrocephaly
05

Safety considerations

Loss-of-function and gain-of-function mutations cause diverse neurological and developmental phenotypeschallenges involve neurocognitive, behavioral, and systemic effectsX-linked inheritance complicates genetic counseling
06

Interacting drugs

None established (no clinically validated drugs targeting CLCN4 as of now)
07

Biomarkers

None established (no validated biomarkers for CLCN4 activity in clinical use)

Beyond the preview

Go deeper on Chloride channel protein 4 (CLCN4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chloride channel protein 4 (CLCN4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call